• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MKK4的自抑制状态:通过分子动力学模拟研究磷酸化、假定的二聚化及R134W突变体

The autoinhibited state of MKK4: Phosphorylation, putative dimerization and R134W mutant studied by molecular dynamics simulations.

作者信息

Shevchenko Ekaterina, Poso Antti, Pantsar Tatu

机构信息

Dept of Internal Medicine VIII, University Hospital Tübingen, Otfried-Müller-Strasse 14, 72076 Tübingen, Germany.

School of Pharmacy, University of Eastern Finland, Yliopistonranta 1C, 70210 Kuopio, Finland.

出版信息

Comput Struct Biotechnol J. 2020 Sep 20;18:2687-2698. doi: 10.1016/j.csbj.2020.09.017. eCollection 2020.

DOI:10.1016/j.csbj.2020.09.017
PMID:33101607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7550801/
Abstract

Protein kinases are crucial components of the cell-signalling machinery that orchestrate and convey messages to their downstream targets. Most often, kinases are activated upon a phosphorylation to their activation loop, which will shift the kinase into the active conformation. The Dual specificity mitogen-activated protein kinase kinase 4 (MKK4) exists in a unique conformation in its inactive unphosphorylated state, where its activation segment appears in a stable α-helical conformation. However, the precise role of this unique conformational state of MKK4 is unknown. Here, by all-atom molecular dynamics simulations (MD simulations), we show that this inactive state is unstable as monomer even when unphosphorylated and that the phosphorylation of the activation segment further destabilizes the autoinhibited α-helix. The specific phosphorylation pattern of the activation segment has also a unique influence on MKK4 dynamics. Furthermore, we observed that this specific inactive state is stable as a dimer, which becomes destabilized upon phosphorylation. Finally, we noticed that the most frequent MKK4 mutation observed in cancer, R134W, which role has not been disclosed to date, contributes to the dimer stability. Based on these data we postulate that MKK4 occurs as a dimer in its inactive autoinhibited state, providing an additional layer for its activity regulation.

摘要

蛋白激酶是细胞信号传导机制的关键组成部分,它们协调并将信息传递给下游靶点。大多数情况下,激酶在其激活环发生磷酸化后被激活,这会使激酶转变为活性构象。双特异性丝裂原活化蛋白激酶激酶4(MKK4)在其未磷酸化的无活性状态下以独特的构象存在,其激活片段呈稳定的α螺旋构象。然而,MKK4这种独特构象状态的确切作用尚不清楚。在这里,通过全原子分子动力学模拟(MD模拟),我们表明即使未磷酸化,这种无活性状态作为单体也是不稳定的,并且激活片段的磷酸化会进一步破坏自抑制α螺旋的稳定性。激活片段的特定磷酸化模式对MKK4动力学也有独特影响。此外,我们观察到这种特定的无活性状态作为二聚体是稳定的,磷酸化后会变得不稳定。最后,我们注意到在癌症中观察到的最常见的MKK4突变R134W(其作用迄今尚未公开)有助于二聚体的稳定性。基于这些数据,我们推测MKK4在其无活性的自抑制状态下以二聚体形式存在,为其活性调节提供了额外的层面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/82ff6f12fd1b/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/8bcf10ac24b3/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/92220fbc0eb9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/92f9b8626ae9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/de0406317aef/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/dc27206afb71/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/c06c935482b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/91e53e05ac1f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/82ff6f12fd1b/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/8bcf10ac24b3/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/92220fbc0eb9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/92f9b8626ae9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/de0406317aef/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/dc27206afb71/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/c06c935482b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/91e53e05ac1f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c59/7550801/82ff6f12fd1b/gr7.jpg

相似文献

1
The autoinhibited state of MKK4: Phosphorylation, putative dimerization and R134W mutant studied by molecular dynamics simulations.MKK4的自抑制状态:通过分子动力学模拟研究磷酸化、假定的二聚化及R134W突变体
Comput Struct Biotechnol J. 2020 Sep 20;18:2687-2698. doi: 10.1016/j.csbj.2020.09.017. eCollection 2020.
2
Chemotherapeutic drug selectivity between wild-type and mutant BRaf kinases in colon cancer.结肠癌中野生型和突变型BRAF激酶之间的化疗药物选择性
J Mol Model. 2017 Jan;23(1):1. doi: 10.1007/s00894-016-3177-8. Epub 2016 Dec 5.
3
Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.JNK3α1的激活需要MKK4和MKK7两者:体外磷酸化JNK3α1的动力学特征
Biochemistry. 2000 Mar 21;39(11):3141-8. doi: 10.1021/bi992410+.
4
Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.丝裂原活化蛋白激酶激酶4(MKK4)和MKK7对应激激活蛋白激酶1/c-Jun氨基末端激酶(SAPK1/JNK)亚型的协同激活作用。
Biochem J. 2000 Nov 15;352 Pt 1(Pt 1):145-54.
5
Long-range molecular dynamics show that inactive forms of Protein Kinase A are more dynamic than active forms.长程分子动力学表明,蛋白激酶 A 的非活性形式比活性形式更具动态性。
Protein Sci. 2019 Mar;28(3):543-560. doi: 10.1002/pro.3556. Epub 2018 Dec 30.
6
Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation.RIP2激酶的非活性和活性状态结构揭示了激活机制。
PLoS One. 2017 May 18;12(5):e0177161. doi: 10.1371/journal.pone.0177161. eCollection 2017.
7
Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.在前列腺癌进展过程中MKK4、MKK6和MKK7的上调:应激激活蛋白激酶信号在前列腺肿瘤形成中的重要作用。
J Pathol. 2007 Aug;212(4):386-94. doi: 10.1002/path.2194.
8
Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation.细丝蛋白与应激信号激酶 MKK7 和 MKK4 相关,并调节 JNK 的激活。
Biochem J. 2010 Mar 29;427(2):237-45. doi: 10.1042/BJ20091011.
9
Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases.酪氨酸激酶激活与构象柔性:Src 家族酪氨酸激酶的启示。
Acc Chem Res. 2017 May 16;50(5):1193-1201. doi: 10.1021/acs.accounts.7b00012. Epub 2017 Apr 20.
10
The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.磷酸化p38γ的结构为单体结构,并呈现出保守的激活环构象。
Structure. 1999 Sep 15;7(9):1057-65. doi: 10.1016/s0969-2126(99)80173-7.

引用本文的文献

1
Autoinhibited Protein Database: a curated database of autoinhibitory domains and their autoinhibition mechanisms.自身抑制蛋白数据库:一个经过精心整理的自身抑制结构域及其自身抑制机制数据库。
Database (Oxford). 2024 Aug 28;2024. doi: 10.1093/database/baae085.
2
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.首个 MKK4 抑制剂增强肝脏再生并预防肝功能衰竭。
Cell. 2024 Mar 28;187(7):1666-1684.e26. doi: 10.1016/j.cell.2024.02.023. Epub 2024 Mar 14.
3
MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.

本文引用的文献

1
Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.结直肠癌中体细胞单核苷酸变异和插入缺失的全景及其对生存的影响。
Nat Commun. 2020 Jul 20;11(1):3644. doi: 10.1038/s41467-020-17386-z.
2
The current understanding of KRAS protein structure and dynamics.目前对KRAS蛋白结构与动力学的理解。
Comput Struct Biotechnol J. 2019 Dec 26;18:189-198. doi: 10.1016/j.csbj.2019.12.004. eCollection 2020.
3
Ensemble structural analyses depict the regulatory mechanism of non-phosphorylated human MAP2K4.
MKK4 抑制剂:最新的研发进展与治疗潜力。
Int J Mol Sci. 2023 Apr 19;24(8):7495. doi: 10.3390/ijms24087495.
4
Understanding gilteritinib resistance to FLT3-F691L mutation through an integrated computational strategy.通过综合计算策略了解 gilteritinib 对 FLT3-F691L 突变的耐药性。
J Mol Model. 2022 Aug 6;28(9):247. doi: 10.1007/s00894-022-05254-0.
5
Mechanistic Insights into the Mechanism of Inhibitor Selectivity toward the Dark Kinase STK17B against Its High Homology STK17A.深入了解抑制剂对高同源性激酶 STK17A 中的暗激酶 STK17B 的选择性作用机制。
Molecules. 2022 Jul 21;27(14):4655. doi: 10.3390/molecules27144655.
6
Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding?蛋白激酶的调节脊柱 RS3 残基:小分子激酶抑制剂结合的亲脂性旁观者还是决定性因素?
Biochem Soc Trans. 2022 Feb 28;50(1):633-648. doi: 10.1042/BST20210837.
7
Deciphering the Mechanism of Gilteritinib Overcoming Lorlatinib Resistance to the Double Mutant I1171N/F1174I in Anaplastic Lymphoma Kinase.解析吉列替尼克服间变性淋巴瘤激酶双突变I1171N/F1174I对洛拉替尼耐药机制
Front Cell Dev Biol. 2021 Dec 23;9:808864. doi: 10.3389/fcell.2021.808864. eCollection 2021.
8
Mechanism of activation and the rewired network: New drug design concepts.激活机制和重布线网络:新药设计概念。
Med Res Rev. 2022 Mar;42(2):770-799. doi: 10.1002/med.21863. Epub 2021 Oct 25.
整体结构分析描绘了非磷酸化人 MAP2K4 的调控机制。
Biochem Biophys Res Commun. 2020 Jan 1;521(1):106-112. doi: 10.1016/j.bbrc.2019.10.086. Epub 2019 Oct 18.
4
OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules.OPLS3e:扩展适用于类药物小分子的力场覆盖范围。
J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874. doi: 10.1021/acs.jctc.8b01026. Epub 2019 Mar 4.
5
Orange is the new black: Kinases are the new master regulators of tumor suppression.橙色即新黑:激酶成为肿瘤抑制的新主控调节因子。
IUBMB Life. 2019 Jun;71(6):738-748. doi: 10.1002/iub.1981. Epub 2018 Dec 11.
6
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
7
Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.基于截断和基序的泛癌分析揭示了肿瘤抑制激酶。
Sci Signal. 2018 Apr 17;11(526):eaan6776. doi: 10.1126/scisignal.aan6776.
8
Kinase inhibitors: the road ahead.激酶抑制剂:前路漫漫。
Nat Rev Drug Discov. 2018 May;17(5):353-377. doi: 10.1038/nrd.2018.21. Epub 2018 Mar 16.
9
Kinase-targeted cancer therapies: progress, challenges and future directions.激酶靶向癌症疗法:进展、挑战与未来方向。
Mol Cancer. 2018 Feb 19;17(1):48. doi: 10.1186/s12943-018-0804-2.
10
Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis.死亡结构域二聚化介导的 RIPK1 激活控制坏死性凋亡和 RIPK1 依赖性细胞凋亡。
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2001-E2009. doi: 10.1073/pnas.1722013115. Epub 2018 Feb 12.